These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7691347)

  • 1. High frequency gene targeting using insertional vectors.
    Dickinson P; Kimber WL; Kilanowski FM; Stevenson BJ; Porteous DJ; Dorin JR
    Hum Mol Genet; 1993 Aug; 2(8):1299-302. PubMed ID: 7691347
    [No Abstract]   [Full Text] [Related]  

  • 2. Disruption of the cystic fibrosis transmembrane conductance regulator gene in embryonic stem cells by gene targeting.
    Ratcliff R; Evans MJ; Doran J; Wainwright BJ; Williamson R; Colledge WH
    Transgenic Res; 1992 Jul; 1(4):177-81. PubMed ID: 1284482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward an animal model of cystic fibrosis: targeted interruption of exon 10 of the cystic fibrosis transmembrane regulator gene in embryonic stem cells.
    Koller BH; Kim HS; Latour AM; Brigman K; Boucher RC; Scambler P; Wainwright B; Smithies O
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10730-4. PubMed ID: 1720548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of a severe cystic fibrosis mutation in mice by gene targeting.
    Ratcliff R; Evans MJ; Cuthbert AW; MacVinish LJ; Foster D; Anderson JR; Colledge WH
    Nat Genet; 1993 May; 4(1):35-41. PubMed ID: 7685652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful targeting of the mouse cystic fibrosis transmembrane conductance regulator gene in embryonal stem cells.
    Dorin JR; Dickinson P; Emslie E; Clarke AR; Dobbie L; Hooper ML; Halford S; Wainwright BJ; Porteous DJ
    Transgenic Res; 1992 Mar; 1(2):101-5. PubMed ID: 1284480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cystic fibrosis mutation, Y109C, in the first transmembrane domain of CFTR.
    Schaedel C; Kristoffersson AC; Kornfält R; Holmberg L
    Hum Mol Genet; 1994 Jun; 3(6):1001-2. PubMed ID: 7524909
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting frequency for deletion vectors in embryonic stem cells.
    Zhang H; Hasty P; Bradley A
    Mol Cell Biol; 1994 Apr; 14(4):2404-10. PubMed ID: 8139544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis in the mouse by targeted insertional mutagenesis.
    Dorin JR; Dickinson P; Alton EW; Smith SN; Geddes DM; Stevenson BJ; Kimber WL; Fleming S; Clarke AR; Hooper ML
    Nature; 1992 Sep; 359(6392):211-5. PubMed ID: 1382232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis gene therapy.
    Colledge WH
    Curr Opin Genet Dev; 1994 Jun; 4(3):466-71. PubMed ID: 7522673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative splicing of the first nucleotide binding fold of CFTR in mouse testes is associated with specific stages of spermatogenesis.
    Delaney SJ; Koopman P; Lovelock PK; Wainwright BJ
    Genomics; 1994 Apr; 20(3):517-8. PubMed ID: 7518412
    [No Abstract]   [Full Text] [Related]  

  • 11. Introduction of a point mutation into the mouse genome by homologous recombination in embryonic stem cells using a replacement type vector with a selectable marker.
    Rubinstein M; Japón MA; Low MJ
    Nucleic Acids Res; 1993 Jun; 21(11):2613-7. PubMed ID: 8392702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The length of homology required for gene targeting in embryonic stem cells.
    Hasty P; Rivera-Pérez J; Bradley A
    Mol Cell Biol; 1991 Nov; 11(11):5586-91. PubMed ID: 1656234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a 31-bp insertion (3860ins31) in exon 20 of the cystic fibrosis (CFTR) gene.
    Chillón M; Casals T; Nunes V; Giménez J; Estivill X
    Hum Mol Genet; 1993 Aug; 2(8):1317-8. PubMed ID: 7691350
    [No Abstract]   [Full Text] [Related]  

  • 14. Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels.
    Delaney SJ; Rich DP; Thomson SA; Hargrave MR; Lovelock PK; Welsh MJ; Wainwright BJ
    Nat Genet; 1993 Aug; 4(4):426-31. PubMed ID: 7691356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target frequency and integration pattern for insertion and replacement vectors in embryonic stem cells.
    Hasty P; Rivera-Pérez J; Chang C; Bradley A
    Mol Cell Biol; 1991 Sep; 11(9):4509-17. PubMed ID: 1875936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the ovine cystic fibrosis transmembrane conductance regulator gene.
    Tebbutt SJ; Wardle CJ; Hill DF; Harris A
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2293-7. PubMed ID: 7534416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cAMP-inducible chloride conductance in mouse fibroblast lines stably expressing the human cystic fibrosis transmembrane conductance regulator.
    Rommens JM; Dho S; Bear CE; Kartner N; Kennedy D; Riordan JR; Tsui LC; Foskett JK
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7500-4. PubMed ID: 1715567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis: prospects for therapy.
    Porteous DJ; Alton EW
    Bioessays; 1993 Jul; 15(7):485-6. PubMed ID: 7691059
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of four new mutations in the cystic fibrosis transmembrane conductance regulator gene: I148T, L1077P, Y1092X, 2183AA-->G.
    Bozon D; Zielenski J; Rininsland F; Tsui LC
    Hum Mutat; 1994; 3(3):330-2. PubMed ID: 7517268
    [No Abstract]   [Full Text] [Related]  

  • 20. Two novel mutations in the transmembrane domains of the CFTR gene in subjects of Sardinian descent.
    Saba L; Leoni GB; Meloni A; Faà V; Cao A; Rosatelli MC
    Hum Mol Genet; 1993 Oct; 2(10):1739-40. PubMed ID: 7505693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.